100 related articles for article (PubMed ID: 2010621)
1. Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen.
Grohmann U; Romani L; Binaglia L; Fioretti MC; Puccetti P
J Immunol Methods; 1991 Mar; 137(1):9-15. PubMed ID: 2010621
[TBL] [Abstract][Full Text] [Related]
2. Immunization of mice and rabbits by intrasplenic deposition of nanogram quantities of protein attached to Sepharose beads or nitrocellulose paper strips.
Nilsson BO; Svalander PC; Larsson A
J Immunol Methods; 1987 May; 99(1):67-75. PubMed ID: 3571992
[TBL] [Abstract][Full Text] [Related]
3. Immunization with nanogram quantities of nitrocellulose-bound antigen, electroblotted from sodium dodecyl sulphate-polyacrylamide gels.
Larsson A; Nilsson BO
Scand J Immunol; 1988 Mar; 27(3):305-9. PubMed ID: 3353689
[TBL] [Abstract][Full Text] [Related]
4. T cells expressing delayed-type hypersensitivity can be derived from a humorally immune lymphocyte population.
LeClercq SA; Bretscher PA
Eur J Immunol; 1987 Jul; 17(7):949-54. PubMed ID: 3497043
[TBL] [Abstract][Full Text] [Related]
5. Modulation of delayed-type hypersensitivity during the time course of immune response to a protein antigen.
Jacysyn JF; Abrahamsohn IA; Macedo MS
Immunology; 2001 Mar; 102(3):373-9. PubMed ID: 11298838
[TBL] [Abstract][Full Text] [Related]
6. An early component of delayed-type hypersensitivity mediated by T cells and mast cells.
van Loveren H; Meade R; Askenase PW
J Exp Med; 1983 May; 157(5):1604-17. PubMed ID: 6602201
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Scott P; Pearce E; Natovitz P; Sher A
J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
[TBL] [Abstract][Full Text] [Related]
8. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity.
Seki N; Sudo Y; Yoshioka T; Sugihara S; Fujitsu T; Sakuma S; Ogawa T; Hamaoka T; Senoh H; Fujiwara H
J Immunol; 1988 Mar; 140(5):1477-84. PubMed ID: 3257978
[TBL] [Abstract][Full Text] [Related]
9. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
Fuyama S; Komatsu H; Arai S
Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
[TBL] [Abstract][Full Text] [Related]
10. Mouse ear spleen grafts: a model for intrasplenic immunization with minute amounts of antigen.
Cardillo F; Mengel J; Garcia SB; Cunha FQ
J Immunol Methods; 1995 Dec; 188(1):43-9. PubMed ID: 8551037
[TBL] [Abstract][Full Text] [Related]
11. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
[TBL] [Abstract][Full Text] [Related]
12. Intrasplenic immunization with minute amounts of antigen.
Nilsson BO; Larsson A
Immunol Today; 1990 Jan; 11(1):10-2. PubMed ID: 2405872
[TBL] [Abstract][Full Text] [Related]
13. Type II collagen-induced murine arthritis. II. Genetic control of arthritis induction is expressed on L3T4+ T cells required for humoral as well as cell-mediated immune responses to type II collagen.
Seki N; Sudo Y; Yamane A; Sugihara S; Takai Y; Ishihara K; Ono S; Hamaoka T; Senoh H; Fujiwara H
Reg Immunol; 1989; 2(4):203-12. PubMed ID: 2577123
[TBL] [Abstract][Full Text] [Related]
14. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
15. Anti-T-cell humoral and cellular responses in healthy BALB/c mice following immunization with ovalbumin or ovalbumin-specific T cells.
Zhang XY; Liu XG; Wang W; Wang WC; Gao XM
Immunology; 2003 Apr; 108(4):465-73. PubMed ID: 12667208
[TBL] [Abstract][Full Text] [Related]
16. Thymocytes induced by antigen injection into the anterior chamber activate splenic CD8+ suppressor cells and enhance the antigen-induced production of immunoglobulin G1 antibodies.
Li X; Wang Y; Urso D; O'Rourke J; Cone RE
Immunology; 2004 Sep; 113(1):44-56. PubMed ID: 15312135
[TBL] [Abstract][Full Text] [Related]
17. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P
Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136
[TBL] [Abstract][Full Text] [Related]
18. The role of CD4+ cells in vivo on the induction of the immune response to Porphyromonas gingivalis in mice.
Sosroseno W; Bird PS; Gemmell E; Seymour GJ
J Periodontol; 2002 Oct; 73(10):1133-40. PubMed ID: 12416770
[TBL] [Abstract][Full Text] [Related]
19. Evanescent delayed-type hypersensitivity: mediation by effector cells with a short life span.
Askenase PW; Hayden B; Gershon RK
J Immunol; 1977 Nov; 119(5):1830-5. PubMed ID: 303252
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells.
Romani L; Grohmann U; Puccetti P; Rossi MA; Fioretti MC
Int J Immunopharmacol; 1990; 12(7):743-9. PubMed ID: 2292454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
